Capricor Therapeutics (CAPR) FCF Margin Growth (5y) (2016 - 2024)
Capricor Therapeutics (CAPR) FCF Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
66,638.00 |
| Sep 30, 2024 |
64,718.00 |
| Jun 30, 2024 |
12,220.00 |
| Mar 31, 2024 |
67,870.00 |
| Dec 31, 2023 |
47,896.00 |
| Sep 30, 2023 |
127,991.00 |
| Jun 30, 2023 |
66,999.00 |
| Mar 31, 2023 |
103,022.00 |
| Dec 31, 2022 |
-23,075.00 |
| Sep 30, 2022 |
63,112.00 |
| Jun 30, 2021 |
-183,910.00 |
| Mar 31, 2021 |
-778,369.00 |
| Dec 31, 2020 |
-700,522.00 |
| Sep 30, 2020 |
-1.83 Mn |
| Jun 30, 2020 |
-411,445.00 |
| Mar 31, 2020 |
-45,810.00 |
| Dec 31, 2019 |
-88,939.00 |
| Sep 30, 2019 |
-94,905.00 |
| Jun 30, 2019 |
13,777.00 |
| Mar 31, 2019 |
-177,748.00 |
